Pharmaceutical

This function is exclusive for Premium subscribers

  • DATABASE (45)

  • INSIGHTS (22)

    • DATABASE (45)
    • INSIGHTS (22)
  • Sort by
    • All
    • Premium
    • Free

With Allozymes technology, designing industrial enzymes takes months instead of years, helping industries from pharmaceuticals to foodtech get the chemicals they need much faster.

iLoF creates a digital library of optical fingerprints for non-invasive patient screening, early diagnostics and personalized medical treatments.

A plug&play digital health SaaS that connects remotely to medical devices, patients’ smartphones and sensors, which grew HumanITcare’s client base sixfold during Covid-19.

Backed by top Silicon Valley investors, Zipline builds drones that leapfrog inefficient infrastructures delivering lifesaving medical supplies to remote locations worldwide within 30mins.

The first EU company combining beekeeping derivatives and cannabidiol (CBD) properties to harness biodiversity and sustainability in alternative medicine and cosmetics.

Indonesia's first digital health clinic for men, Elio offers free personalized consultations including Covid-19 self-assessments.

East Ventures-backed microbiome personalized skincare firm is also known for helping produce Indonesia's first Covid-19 test kit, as part of state R&D collaboration.

Real-time healthchecks for over 750 diseases in 10 languages across multiple platforms, including free expression via voice and chatbots.

China Merchants Capital (CMC), the investment management platform of China Merchants Group, was established in 2012 with a registered capital of RMB 1 billion. As of the end of 2014, it had assets under management worth nearly US$3 billion. CMC invests mainly in the infrastructure, medical & pharmaceutical, financial services, real estate, high-tech, agriculture & foods, media, equipment machinery, mining and energy sectors, among others.

Established in Shenzhen in 2007, Share Capital has invested in over 100 companies. Some of its portfolio companies – e.g., NavInfo, Perfect World and BGI – have gone public. Its investment team of nearly 50 members manages more than RMB 6 billion worth of assets. Share Capital has set up a healthcare fund of RMB 1.5 billion and invested in over 70 health-related projects.

The municipal government of Wuhan launched Wuhan S&T Angel Venture Fund in September 2013. With RMB 300 million under management, the fund is operated by Wuhan S&T Angel Venture Fund Management Co., Ltd. It invests mainly in the information technology, new materials, advanced equipment manufacturing, biomedicine, new energy, automotive, energy conservation, environmental protection and modern agriculture fields.

Alta Life Sciences (Alta LS) was established in 2016. Based in Barcelona, the management team is led by the co-founder of Alta Partners Guy Paul Nohra, a leading pioneer VC in life sciences. Alta Partners has funded over 150 companies since 1996. Alta LS specializes in the life sciences sector in Spain and abroad, targeting biotech, genomics, medical devices, diagnostics and digital health. It also acts as a bridge fund, connecting the Spanish life sciences ecosystem to VC experts in Silicon Valley. Investment is available for all stages of development, with focus mainly on seed and Series A funding.

WuXi AppTec is a Chinese company that specializes in the outsourcing of R&D in the pharmaceuticals, biotechnology and medical devices sectors. Listed on the Hong Kong Stock Exchange, WuXi AppTec has invested in drug development and healthcare firms globally. Its portfolio includes Insilico Medicine, which is developing an AI platform for drug development, brain disease research firm Verge Genomics and Indonesian healthcare platform Halodoc.

Shanghai Zhangjiang Haocheng Venture Capital Co., Ltd. (Zhangjiang Haocheng) was founded in 2007 as a wholly-owned subsidiary of listed real estate developer Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd. It has invested RMB 2.5 billion in high-tech startups.

Yuexiu Industrial Fund is a fund management company founded by Yuexiu Group in Guangzhou in August 2011. It works as an investment arm of Yuexiu Group and invests mainly in emerging industries. As at November 2018, it had RMB 50 billion under its management.

Your payment was not successful.

Please make sure you have entered your payment details correctly. Or try again in a few moments.

small logo

The discount code you entered is invalid

Please make sure you have entered your discount code correctly. Or try again in a few moments.

Download successful.

Your sample has been sent. Please check your email.

Our Privacy and Cookies policies and our Terms of Use may have been updated since your last visit. By continuing to browse this website, you consent to our use of cookies, as well as to our Terms of Use and Privacy Policy, which provides additional information about how we process your data. This website uses cookies to enhance your user experience. Please read our Cookies Policy for more information on how we use cookies, as well as instructions on how to disable cookies. You may disable cookies through your internet browser settings, however this may result in some parts of the website not working properly for you.